A Double-Blind, Placebo-Controlled Study of Intravenous Peramivir in Acute Influenza Patients
Phase of Trial: Phase II
Latest Information Update: 12 Oct 2014
At a glance
- Drugs Peramivir (Primary)
- Indications Influenza virus infections
- Focus Registrational; Therapeutic Use
- Sponsors Shionogi
- 16 Aug 2010 Results were published in Antimicrobial Agents and Chemotherapy.
- 04 Nov 2009 According to a Shionogi media release, a New Drug Application has been filed based on the results of this and another trial (see profile 700047064).
- 31 Oct 2008 Secondary endpoints met according to BioCryst media release.